Evaluación positiva de medicamentos: febrero, marzo y abril 2023 / Positive assessment of drugs: february, march and april 2023
Sanid. mil
; 79(2): 111-117, jun. 2023.
Article
in Es
| IBECS
| ID: ibc-230413
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
RESUMEN
Se reseñan los medicamentos evaluados y con dictamen positivo por comisión de expertos de la Agencia Española de Medicamentos y Productos Sanitarios o de la Agencia Europea del Medicamento hechos públicos en febrero, marzo y abril de 2023 considerados de mayor interés para los profesionales sanitarios. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento. (AU)
ABSTRACT
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency issued in February, March and April 2023, and considered of interest to healthcare professionals, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product. (AU)
Key words
Espironolactona (Qaialdo®); Futibatinib (Lytgobi®); Glofitamab (Columvi®); ivosidenib (Tibsovo/Tidhesco®); Mavacamten (Camzyos®); Mirikizumab (Omvoh®); Niraparib/abiraterona acetato (Akeegar®); Pegunigalsidasa alfa (Elfabrio®); Pirtobrutinib (Jaypirca®); Ruxolitinib (Opzelura®); Sirolimus (Hyftor®); Tiosulfato sódico (Pedmarqsi®); ublituximab (Briumvi®); Vacuna Covid-19; Recombinante con adyuvante, (Bimervax®); Vacuna del virus respiratorio sincitial; Recombinante; Adyuvada (Arexvy®); Vadadustat (Vafseo®); Futibatinib (Lytgobi®); Glofitamab (Columvi®); Ivosidenib (Tibsovo/Tidhesco®); Mavacamten (Camzyos®); Mirikizumab (Omvoh®); Niraparib/abiraterona acetate (Akeegar®); Pegunigalsidasa alfa (Elfabrio®); Pirtobrutinib (Jaypirca®); Ruxolitinib (Opzelura®); Sirolimus (Hyftor®); Tiosulfato sódico (Pedmarqsi®); Ublituximab (Briumvi®); Vacuna Covid-19; Recombinant with adjuvant (Bimervax®); Respiratory virus vaccine sincitial; Recombinant; Adjuvant (Arexvy®); Vadadustat (Vafseo®)
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Pharmaceutical Preparations
/
Drug Evaluation
Language:
Es
Journal:
Sanid. mil
Year:
2023
Document type:
Article